These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora. Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517 [TBL] [Abstract][Full Text] [Related]
7. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study. Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study. Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507 [TBL] [Abstract][Full Text] [Related]
9. The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis. Piekarska K; Zacharczuk K; Wołkowicz T; Mokrzyś M; Wolaniuk N; Nowakowska M; Szempliński S; Dobruch J; Gierczyński R Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):81. PubMed ID: 34876123 [TBL] [Abstract][Full Text] [Related]
10. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy. Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546 [TBL] [Abstract][Full Text] [Related]
11. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy. Summers SJ; Patel DP; Hamilton BD; Presson AP; Fisher MA; Lowrance WT; Southwick AW World J Urol; 2015 Dec; 33(12):2001-7. PubMed ID: 25935330 [TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital. Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990 [TBL] [Abstract][Full Text] [Related]
13. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy. Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416 [TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study. Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957 [TBL] [Abstract][Full Text] [Related]
15. Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy. Tan WP; Papagiannopoulos D; Latchamsetty KC; Wilson N; O'Block N; Raff L; Mena Lora A; Coogan CL; Abern MR Prostate Cancer Prostatic Dis; 2019 May; 22(2):268-275. PubMed ID: 30279581 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy. Tsu JH; Ma WK; Chan WK; Lam BH; To KC; To WK; Ng TK; Liu PL; Cheung FK; Yiu MK Urology; 2015 Jan; 85(1):15-21. PubMed ID: 25444632 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030 [TBL] [Abstract][Full Text] [Related]
18. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis. Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305 [TBL] [Abstract][Full Text] [Related]
19. Routine Ertapenem Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy does Not Select for Carbapenem Resistant Organisms: A Prospective Cohort Study. Bloomfield MG; Page MJ; McLachlan AG; Studd RC; Blackmore TK J Urol; 2017 Aug; 198(2):362-368. PubMed ID: 28288838 [TBL] [Abstract][Full Text] [Related]
20. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli. Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]